Each tablet contains loratadine 10 mg and excipients q.s. (lactose monohydrate, maize starch, magnesium stearate).
Box of 2 blisters x 10 tablets.
Treatment of symptoms associated with allergic rhinitis (sneezing, rhinorrhea, itching as well as ocular itching and burning), chronic rhinitis, acute and chronic urticaria, allergic dermatitis.
Hypersensitivity to loratadine.
- Patients with renal insufficiency should be given a lower initial dose.
- Use in pregnancy: Safe use of loratadine during pregnancy has not been established. Therefore, loratadine should only be used when the potential benefits of its use outweigh the possible risks.
- Use in lactation: Loratadine is excreted in breast milk. Because of the increased risk of antihistamines for infants, decision should be made whether to discontinue nursing or discontinue the drug.
- Children under 2 years of age: Efficacy of loratadine in children under 2 years of age has not yet been established, so loratadine should be used with caution.
- Loratadine should not be used concomitantly with alcohol.
- Use with caution in patients concomitantly treated with erythromycin, ketoconazole or cimetidine.
Headache, drowsy, dry mouth, gastricism, allergy. At doses less than 40 mg per day, side effects are mild and minor in comparison to placebo.
The physician should be informed any side effects during the treatment with RINCONAD.
Dosage and Administration
- Adults and children over 12 years: 1 tablet per day.
- Children from 2-12 years < 30 kg: 5 mg per day.
> 30 kg: 1 tablet per day.
- Patients with liver failure or renal insufficiency: Single initial dose of 5 mg daily or single dose of 10 mg every 2 days.
RINCONAD can be taken with or without food.
Store in a dry and cool place (below 300C). Keep out of reach of children.
Read leaflet carefully before use.
For more information, consult your physician.